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72.2%, respectively).  Conclusion: EUS may be a new useful 
imaging modality for prediction of severity of AP and may 
have prognostic significance in the early phase of AP. 
 Copyright © 2011 S. Karger AG, Basel and IAP 
 Introduction 
 Acute pancreatitis (AP) is an inflammatory disease 
occurring in a previously normal pancreas, and usually 
has a benign course with low mortality. However, approx-
imately 20% of patients may develop a more severe form 
of the disease with evidence of organ dysfunction and se-
vere acute pancreatitis (SAP), with mortality rates ap-
proaching 30%  [1] .
 Dynamic scoring systems using clinical, biochemical 
and radiological criteria are useful to identify patients 
who are developing SAP and may require early support. 
Overlying intestinal gas and the retroperitoneal location 
of the pancreas distant from the abdominal wall can im-
pair the visualization of this organ with transabdominal 
ultrasonography.
 Endoscopic ultrasonography (EUS) can show the 
whole pancreas with details of the parenchymal structure 
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 Abstract 
 Background/Aims: Endoscopic ultrasonography (EUS) is a 
useful modality to diagnose causes of pancreatitis. The role 
of EUS for prediction of pancreatitis severity has not been 
studied. The aim of this study was to identify the utility of 
EUS in determining the severity of acute pancreatitis (AP). 
 Methods: All patients diagnosed with pancreatitis consecu-
tively underwent EUS on the 2nd day of their admission. At-
lanta criteria were used as the severity index of pancreatitis. 
 Results: During the study period, 114 patients (74 females, 
40 males; mean age of 53.03  8 17.7 years) were enrolled in 
the study. The most common cause of AP was gallstone 
(78.9%). According to the Atlanta criteria, pancreatitis was 
mild in 72 (63.2%) and severe in 42 (36.8%) patients. In uni-
variate analysis, the presence of peripancreatic edema, pan-
creas inhomogeneity, common bile duct dilation and ascites 
were associated with severe pancreatitis. In multivariate 
analysis, only the presence of peripancreatic edema in EUS 
correlated with the severity of AP according to the Atlanta 
criteria (sensitivity, specificity and accuracy: 65.8, 75.7 and 
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and peripancreatic changes as well. In addition, EUS may 
show the presence of microlithiasis, occult pancreatic 
malignancies and pancreas divisum, conditions which 
are not detected easily by transabdominal ultrasonogra-
phy or CT scan. These conditions can cause and present 
as AP.
 The close proximity of the endoscopic ultrasound 
probe to the pancreas results in high spatial resolution 
that is superior to that of CT and MRI. In addition, EUS 
is a minimally invasive procedure that does not share the 
relatively high complication rate of endoscopic retro-
grade cholangiopancreatography. Due to these advantag-
es, EUS has evolved into an important technique in the 
evaluation of pancreatobiliary disease.
 However, the role of EUS in the assessment of the se-
verity of AP is not clear. The aim of this study was to as-
sess the clinical impact of EUS in the prediction of sever-
ity of AP.
 Methods and Patients 
 All patients diagnosed with AP and who presented directly to 
our center consecutively underwent EUS on the 2nd day of their 
admission. AP was defined as a serum amylase more than 3 times 
the upper limit of normal associated with epigastric pain, back 
pain and epigastric tenderness.
 The cause of the pancreatitis was determined based on the pa-
tient’s history of alcohol and drug use, transabdominal ultraso-
nography, EUS and magnetic resonance cholangiopancreatogra-
phy.
 An abdominal CT scan was performed for patients with clini-
cal SAP (more than 4 days in the hospital or evidence of infection, 
such as high fever and end organ damages).
 The criteria used for the severity index was the Atlanta criteria, 
with the exception of the APACHE score. Bradley  [2] reported the 
criteria for SAP developed at the international symposium on AP 
held in Atlanta, Georgia ( table 1 ).
 The study was carried out prospectively at a single center by 1 
investigator. EUS was performed while the patient was in the left 
lateral decubitus position under conscious sedation with mid-
azolam (2.5–5 mg) with or without intravenous pethidine (25–50 
mg). The uncinate process and head of pancreas were scanned 
from the duodenum, and the body and tail of the pancreas was 
scanned from the stomach. All EUS procedures were performed 
by an expert endosonographer. EUS was performed using a ra-
dial echoendoscope (EG-363 DUR, Pentax Optical Co. Ltd., To-
kyo, Japan) with a frequency of 7.5 MHz.
 In addition to the etiology of pancreatitis, the other variables 
were assessed by EUS ( table 2 ). Because EUS was performed on 
the 2nd day of admission, the endosonographer was blinded to 
either the clinical outcome or the CT findings.
 The study was approved by the institutional review board of 
the Digestive Diseases Research Center of Tehran University of 
Medical Sciences, according to the Declaration of Helsinki. The 
investigation was approved by the local ethical committee. In-
formed consent was obtained according to the guidelines of the 
institute.
 Patients, depending on their criteria, were divided into mild 
and severe outcome groups and were statistically compared using 
  2 for categorical variables and Student’s t test for continuous 
variables (data normally distributed). The potential role of risk 
factors were evaluated by univariate logistic regression analyses 
and results with a p value of less than 0.20 were entered into the 
backward multivariable logistic regression model. Collinearity 
was assessed by correlation analysis between any of the indepen-
dent variables (correlation coefficient greater than 0.50). Good-
ness-of-fit in the regression model was evaluated by the Hosmer-
Lemeshow test (p  ! 0.05). Adjusted OR with 95% CI were calcu-
lated. Statistical analyses were performed using STATA version 8/
SE (Stata Corp., College Station, Tex., USA). Statistical signifi-
cance was set at p  ! 0.05 (2 tails).
 Results 
 From February 2008 to November 2009, 114 eligible 
patients were recruited. The mean  8 SD and median of 
age were 53.03  8 17.7 and 55 years, respectively. Most of 
the patients were women (74 cases, 64.9%). The causes of 
pancreatitis were the following: gallstone in 90 (78.9%), 
idiopathic pancreatitis in 9 (7.8%), postendoscopic retro-
grade cholangiopancreatography pancreatitis in 5 (4.3%), 
alcohol drinking in 4 (3.5%), periampullary tumors in 3 
(3.5%), hypertriglyceridemia in 1 (1.1%) and sphincter of 
Oddi dysfunction in 2 (1.8%) cases. There were 72 (63.2%) 
and 42 (36.8%) cases of mild and severe AP, respectively. 
Differences in EUS findings between mild and severe 
pancreatitis groups are presented in  table 2 .
 The presence of ascites, pancreatic inhomogeneity, 
common bile duct (CBD) diameter and peripancreatic 
edema in the severe pancreatitis group were higher than 
Table 1.  Criteria for severe AP (1 or more of the following)
1 Ranson score on admission ≥3 (or during the first 48 h)
2 APACHE II score ≥8 at any time during course
3 Presence of 1 or more organ failures†
4 Presence of 1 or more local complications*
* Includes pancreatic necrosis, pancreatic abscess and pancre-
atic pseudocyst.
† Organ failures include: shock (systolic blood pressure <90 
mm Hg), pulmonary insufficiency (PaO2 ≤60 mm Hg on room 
air), renal failure (serum creatinine >2 mg/dl after fluid replace-
ment), gastrointestinal bleeding with >500 ml estimated loss 
within 24 h, DIC (thrombocytopenia and hypofibrinogenemia 
and fibrin split products) and severe hypocalcemia (≤7.5 mg/dl).
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the mild group based on the Atlanta criteria. The other 
EUS findings were not significantly different between the 
2 groups. All of the EUS variables, based on the Atlanta 
criteria, were assessed in univariate logistic regression 
analysis ( table 3 ). In the collinearity assessment phase of 
multivariate analysis, the presence of ascites and peripan-
creatic edema were moderately correlated. With the ex-
clusion of ascites, pancreas inhomogeneity and CBD dila-
tion from the model, the final multivariable model was 
exactly the same. Thus, peripancreatic edema had the 
highest correlation with pancreatitis severity according 
to the Atlanta criteria (OR: 5.9, 95% CI: 2.3–15.5). Good-
ness-of-fit for the final model by Hosmer-Lemeshow sta-
tistic (  2 ) was 27.1 (p  ! 0.001). Sensitivity, specificity and 
accuracy of peripancreatic edema were 65.8, 75.7 and 
72.2%, respectively.
 Although all patients underwent abdominal ultraso-
nography before EUS, none of them revealed peripan-
creatic edema. Thirty-one patients with severe pancre-
atitis according to the Atlanta criteria had peripancre-
atic edema in EUS. In the follow-up of these patients, 12 
cases were admitted to the ICU with a mean stay of 2 
weeks, and 4 cases died because of organ failure and sep-
sis. Figure 1 shows peripancreatic edema in a patient 
Table 2. D istribution of EUS variables according to severity of AP 
(based on the Atlanta criteria)
Variables Mild
pancreatitis
(n = 72)
Severe
pancreatitis
(n = 42)
p 
Presence of gall bladder stone(s) 41 (56.9) 28 (66.7) 0.31
Thickened wall gall bladder 27 (37.5) 16 (38.1) 0.95
Duodenal wall thickness 2 (2.8) 0 (0.0) 0.28
Ascites 14 (19.4) 16 (38.1) 0.03
Pancreatic pseudocyst 1 (1.4) 3 (7.1) 0.11 
Pancreatic inhomogeneity 18 (25.0) 21 (50.0) 0.007
Pancreas divisum 0 (0.0) 1 (2.4) 0.19
Peripancreatic LAPs 21 (29.2) 9 (21.4) 0.37
CBD stone(s) 18 (25.0) 11 (26.2) 0.89
Difficulty for CBD visualization 9 (12.5) 5 (11.9) 0.93
CBD diameter, mm 5.680.3 6.780.5 0.047
Pancreatic mass 1 (1.4) 0 (0.0) 0.44
Pancreatic calcification 0 (0.0) 2 (4.8) 0.06 
Peripancreatic edema 18 (25.0) 29 (69.0) <0.0001
PD diameter, mm 2.780.1 2.880.1 0.42
LAPs = Lymphadenopathies; PD = pancreatic duct.
Table 3. R elationship of EUS variables with SAP (based on the 
Atlanta criteria) by univariate logistic regression analysis
Variables OR
(crude)
95% CI p
Presence of gall bladder stone(s) 1.5 0.7–3.3 0.31
Thickened wall gall bladder 1.03 0.5–2.3 0.95
Duodenal wall thickness – – –
Ascites 2.6 1.1–6.0 0.03
Pancreatic pseudocyst 5.5 0.6–54.3 0.30
Pancreatic inhomogeneity 3.0 1.3–6.7 0.008
Pancreas divisum – – –
Peri-pancreatic LAPs 0.7 0.3–1.7 0.37
CBD stone(s) 1.1 0.5–2.5 0.89
Difficulty for CBD visualization 1.0 0.3–3.0 0.93
Increasing 1 mm to the
CBD diameter 1.2 1.0–1.3 0.05
Pancreatic mass – – –
Pancreatic calcification – – –
Peripancreatic edema 6.7 2.9–15.6 <0.0001
Increasing 1 mm to the
PD diameter 1.2 0.8–1.7 0.43
LAPs = Lymphadenopathies; PD = pancreatic duct.
a b
 Fig. 1. Peripancreatic edema as a hy-
poechoic area around the pancreas (ar-
rows,  a ), which is not present in a normal 
pancreas ( b ). 
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with severe pancreatitis compared with a normal pan-
creas. All patients with severe pancreatitis underwent 
an abdominal CT scan. These patients had severe pan-
creatitis (grade C or D), based on the Balthazar CT se-
verity index  [3] .
 Discussion 
 This study shows that peripancreatic edema in EUS 
may be a new imaging criterion for the early prediction 
of pancreatitis severity. Most patients with AP have a be-
nign course and may be safely managed in a general ward. 
However, early detection of SAP before the development 
of clinical consequences is important. Thus, it is impor-
tant to have scoring systems and early predictors of sever-
ity and mortality in order to determine which patients 
might benefit from more intensive care.
 Several scoring systems have been used to evaluate the 
severity of AP based on clinical and laboratory findings, 
such as Ranson  [4] Glasgow  [5, 6] , APACHE II systems  [7] 
and serum hematocrit  [8] . However, each scoring system 
has its limitations. For example, a meta-analytic Ranson 
scoring system has poor predictive power for the severity 
of AP  [9] . The APACHE II system cannot define a cutoff 
between moderate and severe AP  [10] and infected and 
sterile necrosis  [11–13] . It also shows a low positive pre-
dictive value (43%) for SAP  [14] .
 To our knowledge, this study is the first one that shows 
the probable utility of EUS in prediction of pancreatitis 
severity. Another important finding of our study is the 
prediction of pancreatitis severity in an early phase of AP.
 In patients with AP, EUS may be helpful in the diag-
nosis of occult cholelithiasis, biliary sludge, pancreas di-
visum, evidence of early chronic pancreatitis or an occult 
neoplasm, which can present as AP and is not diagnosed 
easily (if not impossible) by other imaging modalities. In 
biliary pancreatitis, EUS allows accurate detection of 
CBD stones and can be used to select patients who will 
benefit from endoscopic retrograde cholangiopancrea-
tography  [15] . Although the majority of CBD stones pass 
spontaneously, 20–30% of patients with gallstone pancre-
atitis will have persistent CBD stones that fail to cross the 
ampulla. Unfortunately, traditional clinical and radio-
graphic criteria used to predict CBD stones, such as ele-
vated liver enzymes and ultrasonography, are nonspecif-
ic and unreliable  [16–19] .
 Overlying intestinal gas and the retroperitoneal loca-
tion of the pancreas distant from the abdominal wall can 
impair the visualization of this organ with transabdomi-
nal ultrasonography. This may be the cause this modali-
ty’s inability to detect peripancreatic edema.
 In the current study, the presence of peripancreatic 
edema in EUS was correlated with the severity of pancre-
atitis. In addition, the presence of peripancreatic edema 
was correlated with grade C and D in the Balthazar CT 
severity index  [3] . Therefore, we can diagnose the cause 
of pancreatitis as well as to assess the severity of pancre-
atitis with EUS. In addition, EUS can show pancreatic 
complications and guide aspiration with a fine needle 
and/or drainage with stents and a necrosectomy if neces-
sary  [20–22] . Thus, EUS may be a ‘one-stop shop’ proce-
dure in patients with AP.
 The other finding of our study is the detection of SAP 
on the 2nd day of admission, which is very important for 
choosing more aggressive and earlier care for this high-
risk group of patients. As we showed, 31 patients with 
severe pancreatitis according to the Atlanta criteria had 
peripancreatic edema on EUS. In the follow-up of these 
patients, 12 cases were admitted to the ICU with a long 
duration of stay and 4 cases died because of organ failure 
and sepsis.
 One of the limitations of our study is that abdominal 
CT was done only for patients with clinical based (not 
Atlanta-based) severe pancreatitis. However, patients 
with mild pancreatitis had a benign course and left the 
hospital without complications.
 Moreover, CT scan is not required on the 1st day of AP, 
unless there are other possible diagnoses. A CT scan is 
required only in patients who are deteriorating or have 
SAP, determined clinically and by APACHE II score. It 
takes a few days for pancreatic necrosis to develop, and 
treatment is unlikely to be altered based on CT findings. 
In addition, like ultrasonography, a CT scan is not sensi-
tive for detection of biliary stone or microlithiasis as the 
main cause of pancreatitis.
 Although we have cited some crucial points in favor of 
EUS, CT remains the accepted standard of reference ex-
amination in AP because it is more available than MRI 
and EUS, and it is more sensitive in detecting calcifica-
tions and air bubbles, findings that are not easily detect-
able by EUS and ultrasonography.
 In summary, we showed that EUS could be a new im-
aging modality for the early prediction of AP severity. 
However, more studies in other centers are needed to val-
idate the role of EUS in the staging of severity and prog-
nosis of AP.
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